Retrograde Pancreatography and Cholangiography by Fiber Duodenoscope

Takagi, Kunio; Ikeda, Seiyo; Nakagawa, Y; Sakaguchi, N; Takahashi, Takashi; Kumakura, K; Maruyama, Masakazu; Someya, Naiki; Nakano, Hiroshi; Takada, Tasuku; Takekoshi, T; Kin, Takekazu

doi:10.1016/s0016-5085(19)33745-x

Cited by 101 publications

(27 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The introduction of fibre-optic endoscopy (Hirschowitz, Curtiss, Peters, and Pollard 1958) and the subsequent development of a cannulating endoscope (Takagi, Go, Sugiura, Futagawa, and Hioki, 1969;Oi, Ichioka, and Takemoto, 1969;Oi, 1970;Takagi, Ikeda, Nakayama et al, 1970) have led to the widespread use of endoscopic retrograde choledochopancreatography (ERCP) in the diagnosis and management of pancreatic and biliary tract disease (Qi, 1970;Oi, Takemoto, and Nakayama, 1970;Oi, Kobayashi, and Kono, 1970;Takagi et al, 1970;Ogoshi, Tobita, and Hara, 1970;Fujita, Soma, and Kidokoro, 1970;Demling and Classen, 1970;Kasugai, Kuno, Aoki et al, 1971;Kobayashi, Tanaka, and Tsuneoka, 1971;Salmon, Brown, Htut, Burwood, and Read, 1971a;Cotton, Salmon, Blumgart, Burwood, Davies, Lawrie, Pierce, and Read, 1972;Blumgart, Salmon, Cotton, Davies, Burwood, Beales, Lawrie, Skirving, and Read, 1972;Kasugai, Kuno, Kobayashi, and Hattori, 1972;Burwood, Davies, Lawrie, Blumgart, and Salmon, 1973;. Clinically ERCP is of value both in suspected and in known pancreatic disease.…”

Section: From Bristol Royal Infirmarymentioning

confidence: 99%

Endoscopic retrograde choledochopancreatography in the diagnosis of pancreatic disease.

Salmon¹

1975

Gut

View full text Add to dashboard Cite

Section: From Bristol Royal Infirmarymentioning

confidence: 99%

Endoscopic retrograde choledochopancreatography in the diagnosis of pancreatic disease.

Salmon¹

1975

Gut

View full text Add to dashboard Cite

“…Endoscopic retrograde cholangiopancreatography (ERCP) has revolutionized the diagnosis and treatment of biliary and pancreatic diseases, since first reports were published more than forty years ago (1,2). Selective biliary cannulation is an integral element of interventional procedures such as sphincterotomy, stone removal or stent placement.…”

Section: Introductionmentioning

confidence: 99%

A novel second-generation multibending backward-oblique viewing duodenoscope in ERCP

Toyoizumi

Imazu

Ikeda

et al. 2014

Minimally Invasive Therapy & Allied Technologies

View full text Add to dashboard Cite

show abstract

“…However, it was really put on the map shortly afterwards by several Japanese groups, working with instrument manufacturers to develop appropriate long side-viewing instruments [2][3][4][5]. The technique (initially called ECPGa endoscopic cholangiopancreatographyain Japan) spread throughout Europe in the early 1970s [6][7][8][9][10][11][12][13].…”

mentioning

confidence: 99%

ERCP Overview—A 30‐Year Perspective

Cotton¹

2005

Advanced Digestive Endoscopy: ERCP

View full text Add to dashboard Cite

Endoscopic cannulation of the papilla of Vater was first reported in 1968 [1]. However, it was really put on the map shortly afterwards by several Japanese groups, working with instrument manufacturers to develop appropriate long side-viewing instruments [2][3][4][5]. The technique (initially called ECPGa endoscopic cholangiopancreatographyain Japan) spread throughout Europe in the early 1970s [6][7][8][9][10][11][12][13]. Early efforts were much helped by a multinational workshop at the European Congress in Paris in 1972, organized by the Olympus company. ERCP rapidly became established worldwide as a valuable diagnostic technique, although doubts were expressed in the USA about its feasibility and role [14], and the potential for serious complications soon became clear [15][16][17][18]. ERCP was given a tremendous boost by the development of its therapeutic applications, notably biliary sphincterotomy in the mid-1970s [19-21] and biliary stenting 5 years later [22,23].It is difficult for most gastroenterologists today to imagine the diagnostic and therapeutic situation 30 years ago. There were no scans. Biliary obstruction was diagnosed and treated surgically, with substantial operative mortality. Nonoperative documentation of biliary pathology by ERCP was a huge step forward. Likewise, ERCP was an amazing development in pancreatic investigation at a time when the only available test was laparotomy. The ability to 'see into' the pancreas, and to collect pure pancreatic juice [24], seemed like a miracle. We assumed that ERCP would have a dramatic impact on chronic pancreatitis and pancreatic cancer. Sadly, these expectations are not yet realized, but endoscopic management of biliary obstruction was clearly a major clinical advance, especially in the sick and elderly. The period of 15 or so years from the mid-1970s really constituted a 'golden age' for ERCP. Despite significant risks [25], it was obvious to everyone that ERCP management of duct stones and tumors was easier, cheaper, and safer than available surgical alternatives. Large series were published, including some randomized trials [26][27][28][29][30][31]. Percutaneous transhepatic cholangiography (PTC) and its drainage applications were also developed 1 Advanced Digestive Endoscopy: ERCP Edited by Peter B. Cotton, Joseph Leung

show abstract

Retrograde Pancreatography and Cholangiography by Fiber Duodenoscope

Cited by 101 publications

References 5 publications

Endoscopic retrograde choledochopancreatography in the diagnosis of pancreatic disease.

Endoscopic retrograde choledochopancreatography in the diagnosis of pancreatic disease.

A novel second-generation multibending backward-oblique viewing duodenoscope in ERCP

ERCP Overview—A 30‐Year Perspective

Contact Info

Product

Resources

About